Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project

Lukas Bubendorf*, Urania Dafni, Martin Schobel, Stephen P. Finn, Verena Tischler, Aleksandra Sejda, Antonio Marchetti, Erik Thunnissen, Eric K. Verbeken, Arne Warth, Irene Sansano, Richard Cheney, Ernst Jan M. Speel, Daisuke Nonaka, Kim Monkhorst, Henrik Hager, Miguel Martorell, Spasenija Savic, Keith M. Kerr, Qiang TanZoi Tsourti, Thomas R. Geiger, Roswitha Kammler, Katja Schulze, Ashis Das-Gupta, David Shames, Solange Peters, Rolf A. Stahel, Lungscape Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)143-149
Number of pages7
JournalLung Cancer
Volume111
DOIs
Publication statusPublished - Sep 2017

Keywords

  • Non-small cell lung carcinoma
  • IHC MET overexpression
  • SISH MET amplification
  • MET exon14 mutation
  • CELL LUNG-CANCER
  • COPY NUMBER
  • PROTEIN EXPRESSION
  • TARGETING MET
  • IMMUNOHISTOCHEMISTRY
  • MUTATIONS
  • ADENOCARCINOMAS
  • CARCINOMAS
  • INHIBITORS
  • SURVIVAL

Cite this

Bubendorf, L., Dafni, U., Schobel, M., Finn, S. P., Tischler, V., Sejda, A., Marchetti, A., Thunnissen, E., Verbeken, E. K., Warth, A., Sansano, I., Cheney, R., Speel, E. J. M., Nonaka, D., Monkhorst, K., Hager, H., Martorell, M., Savic, S., Kerr, K. M., ... Lungscape Consortium (2017). Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Lung Cancer, 111, 143-149. https://doi.org/10.1016/j.lungcan.2017.07.021